Current Options and Emerging Biomaterials for Periprosthetic Joint Infection

Current Options and Emerging Biomaterials for Periprosthetic Joint Infection Purpose of Review Infection in the setting of total joint arthroplasty, referred to as periprosthetic joint infection (PJI), is a devastating complication requiring prolonged and costly treatment. The unique environment around an artificial joint and ability of surrounding tissues to sequester bacteria collectively make prevention, diagnosis, and treatment of this condition challenging. In light of the unique pathogenesis of PJI, this review explores the limitations of contemporary treatments and discusses novel treatment options. Recent Findings Recent advancements in local antibiotic delivery platforms for preventing and treating PJI include titanium nanotube arrays, synthetic polymers, resorbable hydrogels, and cyclodextrin-based drug delivery options. In particular, cyclodextrins have facil- itated great advancements in other clinical disorders and have demonstrated early promise as a future option in the arena of PJI. Summary Novel treatment modalities for PJI optimize the implant surfaces to prevent bacterial biofilm formation or provide prolonged intra-articular antibiotic dosing to eradicate bacteria. . . . . . Keywords Periprosthetic joint infection Controlled antibiotic release Polymethylmethacrylate PMMA Calcium sulfate Cyclodextrin Introduction causative organism, treatment often involves prolonged systemic antibiotic therapy and multiple revision surgeries. Periprosthetic joint infection (PJI) following total joint Despite such rigorous treatment measures, PJI patients re- arthroplasty (TJA) is http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Rheumatology Reports Springer Journals

Current Options and Emerging Biomaterials for Periprosthetic Joint Infection

Loading next page...
 
/lp/springer_journal/current-options-and-emerging-biomaterials-for-periprosthetic-joint-NWhCsBVZIt
Publisher
Springer US
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Rheumatology
ISSN
1523-3774
eISSN
1534-6307
D.O.I.
10.1007/s11926-018-0742-4
Publisher site
See Article on Publisher Site

Abstract

Purpose of Review Infection in the setting of total joint arthroplasty, referred to as periprosthetic joint infection (PJI), is a devastating complication requiring prolonged and costly treatment. The unique environment around an artificial joint and ability of surrounding tissues to sequester bacteria collectively make prevention, diagnosis, and treatment of this condition challenging. In light of the unique pathogenesis of PJI, this review explores the limitations of contemporary treatments and discusses novel treatment options. Recent Findings Recent advancements in local antibiotic delivery platforms for preventing and treating PJI include titanium nanotube arrays, synthetic polymers, resorbable hydrogels, and cyclodextrin-based drug delivery options. In particular, cyclodextrins have facil- itated great advancements in other clinical disorders and have demonstrated early promise as a future option in the arena of PJI. Summary Novel treatment modalities for PJI optimize the implant surfaces to prevent bacterial biofilm formation or provide prolonged intra-articular antibiotic dosing to eradicate bacteria. . . . . . Keywords Periprosthetic joint infection Controlled antibiotic release Polymethylmethacrylate PMMA Calcium sulfate Cyclodextrin Introduction causative organism, treatment often involves prolonged systemic antibiotic therapy and multiple revision surgeries. Periprosthetic joint infection (PJI) following total joint Despite such rigorous treatment measures, PJI patients re- arthroplasty (TJA) is

Journal

Current Rheumatology ReportsSpringer Journals

Published: Apr 30, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off